EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer (Q46535209)
Jump to navigation
Jump to search
scientific article published on 6 April 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer |
scientific article published on 6 April 2015 |
Statements
1 reference
EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer (English)
1 reference
Linda T Vahdat
1 reference
Michelle E Melisko
1 reference
Denise A Yardley
1 reference
Tessa Cigler
1 reference
Robert Weaver
1 reference
Mansoor N Saleh
1 reference
Francis P Arena
1 reference
Andres Forero
1 reference
Alison Stopeck
1 reference
Dennis Citrin
1 reference
Ira Oliff
1 reference
Rebecca Bechhold
1 reference
Randa Loutfi
1 reference
Agustin A Garcia
1 reference
Scott Cruickshank
1 reference
Elizabeth Crowley
1 reference
Jennifer Green
1 reference
Thomas Hawthorne
1 reference
Michael J Yellin
1 reference
Thomas A Davis
1 reference
6 April 2015
1 reference
33
1 reference
14
1 reference
1609-1619
1 reference